Kypha buys diagnostics platform and contract development firm Biosensia
Medical diagnostics firm Kypha has acquired diagnostics platform and contract development firm, Biosensia for an undisclosed sum.
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
16 Jul 18
Medical diagnostics firm Kypha has acquired diagnostics platform and contract development firm, Biosensia for an undisclosed sum.
09 Jul 18
3N Diagnostics has entered into an exclusive distribution agreement with Bio-Optica Milan.
09 Jul 18
Thermo Fisher Scientific has unveiled new Phadia 200 instrument to support in the diagnosis of allergy and autoimmunity…
05 Jul 18
Akers Biosciences has announced agreements with six more independent sales representative (ISR) organizations to further expand US sales…
05 Jul 18
Researchers from the Charité – Universitätsmedizin Berlin have developed a new blood test to determine the state of…
22 Jun 18
South Korean in vitro diagnostics firm SD Biosensor has collaborated with the nonprofit organization PATH to advance the…
13 Jun 18
Fujirebio Diagnostics, a consolidated subsidiary of Miraca Holdings, has secured approval from the US Food and Drug Administration…
07 Jun 18
Microbiotica has partnered with Genentech to discover, develop and commercialise biomarkers, targets and medicines for inflammatory bowel disease…
06 Jun 18
Exact Sciences and Mayo Clinic said that their panel of blood-based, DNA biomarkers was successful in accurately detecting…
04 Jun 18
Molecular Health has introduced Version 3.0 of Molecular Health Guide ((MH Guide) software solution, offering improved support for…